Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices 6569 

changes will affect the overall burden to 

respond to this information collection. 

Respondents: Individuals and 

households. 

ANNUAL BURDEN ESTIMATES

Instrument Total number 

of respondents 

Total number 

of responses 

per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

Current Population Survey-Child Support Supplement ................................... 34,500 1 0.03 1,035 

Estimated Total Annual Burden 

Hours: 1,035. 

Comments: The Department 

specifically requests comments on (a) 

whether the proposed collection of 

information is necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) the quality, utility, 

and clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Consideration will be given 

to comments and suggestions submitted 

within 60 days of this publication. 

Authority: 13 U.S.C. 182. 

Mary B. Jones, 

ACF/OPRE Certifying Officer. 

[FR Doc. 2022–02377 Filed 2–3–22; 8:45 am] 

BILLING CODE 4184–41–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; U.S. Repatriation Program 

Forms (OMB#: 0970–0474) 

AGENCY: Office of Human Services 

Emergency Preparedness and Response, 

Administration for Children and 

Families, HHS. 

ACTION: Request for public comment. 

SUMMARY: The Administration for 

Children and Families (ACF) is 

requesting a 3-year extension of the U.S. 

Repatriation Program forms (OMB 

#0970–0474, expiration 4/30/2022). 

There are several changes requested to 

the eight forms. Burden estimates have 

also been updated. 

DATES: Comments due within 60 days of 

publication. In compliance with the 

requirements of the Paperwork 

Reduction Act of 1995, ACF is soliciting 

public comment on the specific aspects 

of the information collection described 

above. 

ADDRESSES: You can obtain copies of the 

proposed collection of information and 

submit comments by emailing 

infocollection@acf.hhs.gov. Identify all 

requests by the title of the information 

collection. 

SUPPLEMENTARY INFORMATION: 

Description: The purpose of the U.S. 

Repatriation Program (Program) is to 

provide temporary assistance to eligible 

U.S. citizens and their dependents 

(repatriates) returned by the Department 

of State from a foreign country because 

of destitution, illness, war, threat of war, 

or a similar crisis, and who are without 

available resources, or (2) mental 

illness. Temporary assistance is 

provided upon their arrival in the 

United States and is available initially 

for up to 90 days from a repatriate’s date 

of arrival in the United States. 

Temporary assistance is provided in the 

form of a service loan and is repayable 

to the U.S. Government. 

Temporary assistance is defined in 42 

U.S.C. 1313(c) as money payments, 

medical care, temporary lodging, 

transportation, and other goods and 

services necessary for the health or 

welfare of individuals, including 

guidance, counseling, and other welfare 

services provided to them within the 

United States upon their arrival in the 

United States. Other goods and services 

may include clothes, food, assistance 

with obtaining identification (driver’s 

license, birth certificate), child care, and 

translation services. 

The ACF Office of Human Services 

Emergency Preparedness and Response 

(OHSEPR), at the U.S. Department of 

Health and Human Services (HHS), 

administers the Program. 

OHSEPR made changes to all eight 

forms to ensure the information 

collected aligns with Program statutes 

and regulations as well as the purpose 

and use of the form. Revisions include 

clarifying statutory authority and 

general instructions on completing and 

submitting the forms. These changes 

make the forms more user friendly. 

OHSEPR also reduced the burden 

estimates to make them more accurate. 

The following is a description of the 

forms and the proposed revisions: 

Emergency Repatriation Eligibility 

Application (Form RR–01) 

The purpose of this form is for U.S. 

citizens and their dependents to request 

temporary assistance during an 

emergency repatriation. Proposed 

revisions include the following: 

• Changing the title of the form from 

‘Emergency and Group Processing 

Form’ to ‘Emergency Repatriation 

Eligibility Application’ 

• Adding the following information: 

Æ Date and time of applicant’s entry 

and exit to the Emergency 

Repatriation Center 

Æ Applicant’s flight information 

Æ Name and contact information for 

responsible person (if main U.S. 

citizen applicant is a minor) 

Æ Gender option (X) for applicant and 

dependents to align with 

Department of State gender 

information on passports 

Æ Option for applicants and 

dependents to provide alternative 

ID number (instead of passport 

number) 

Æ Needs assessment section to 

determine applicant’s needs 

Æ Details about quantity of temporary 

assistance requested 

Æ Language to signatory block to 

specify the meaning of signing the 

form 

Æ Materials/information provided to 

the repatriate 

• Removing eligibility determination 

question regarding availability of 

next of kin/friends to provide 

resources 

Emergency Repatriation 

Reimbursement Request (Form RR–02) 

The purpose of this form is for states 

to request reimbursement for emergency 

repatriation expenditures. Proposed 

revisions include the following: 

• Changing the title of the form from 

‘Emergency and Group Repatriation 

Financial Form’ to ‘Emergency 

Repatriation Reimbursement 

Request’ 

• Modifying information about location 

of service provision 


lotter on DSK11XQN23PROD with NOTICES1
6570 Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices 

• Adding planning/training/exercise as 

a category for reimbursement 

• Clarifying instructions on 

documentation for allowable costs 

Loan Waiver and Deferal Application 

(Form RR–03) 

The purpose of this form is for 

repatriates to request a waiver or 

deferral of their loan for temporary 

assistance received through the U.S. 

Repatriation Program. Proposed 

revisions include the following: 

• Changing the title of the form from 

‘Repatriation Loan Waiver and 

Deferral Request Form’ to ‘Loan 

Waiver and Deferral Application’ 

• Separating fixed monthly expenses 

from loans and liabilities 

• Adding the following information: 

Æ Repatriate’s type of current housing 

Æ Employer’s email address 

Æ Option for repatriate to include 

additional employment 

Æ Assets such as checking/savings 

accounts 

Æ Language to signatory block to 

specify the meaning of signing this 

form 

Æ Name, relationship to repatriate, 

and contact information for 

authorized representative 

• Removing Social Security Number 

(SSN) for dependents 

Routine Repatriation Reimbursement 

Request (Form RR–04) 

The purpose of this form is for state 

and local service providers to submit 

reimbursement requests for providing 

temporary assistance to repatriates 

under the U.S. Repatriation Program. 

Proposed revisions include the 

following: 

• Changing the title of the form from 

‘Non-Emergency Monthly Financial 

Statement Form’ to ‘Routine 

Repatriation Reimbursement 

Request’ 

• Clarifying instructions on 

documentation for allowable costs 

• Revising language on signatory block 

to specify the meaning of signing 

this form 

• Removing these items: 

Æ State or local provider’s 

recommendation for waiver 

approval 

Æ SSN for dependents 

Repatriation Repayment and Privacy 

Agreement (Form RR–05) 

The purpose of this form is for 

repatriates to agree to accept temporary 

assistance under the U.S. Repatriation 

Program, to agree to repay HHS for 

temporary assistance, and to allow HHS 

to share personal information for 

benefits purposes. Proposed revisions 

include the following: 

• Changing the title of the form from 

‘Privacy and Repayment Agreement 

Form’ to ‘Repatriation Repayment 

and Privacy Agreement’ 

• Revising language on signatory block 

to specify the meaning of signing 

the form 

• Clarifying that the Privacy Act 

Statement applies to Repatriation 

forms that collect personal 

identifiable information 

• Adding voluntary demographic 

questions to align with Executive 

Order 13985 (Advancing Racial 

Equity and Support for Underserved 

Communities Through the Federal 

Government) 

• Adding instructions on completing 

the form 

Refusal of Temporary Assistance (Form 

RR–06) 

The purpose of this form is for 

repatriates to refuse to accept temporary 

assistance under the U.S. Repatriation 

Program after receiving information 

about the Program. Proposed revisions 

include adding the following: 

• Instructions on completing the form 

• The country the repatriate returned 

from 

Temporary Assistance Extension 

Request (Form RR–07) 

The purpose of this form is for 

repatriates to request an extension of 

temporary assistance beyond the initial 

90-day eligibility period. Proposed 

revisions include the following: 

• Removing these items: 

Æ SSN for dependents 

Æ ‘‘other reasons’’ as an option for 

justification of request 

• Adding these items: 

Æ Authorized representative 

information 

Æ Sections on household income, 

fixed monthly expenses, and loans 

and liabilities 

Æ Language on signatory block to 

specify meaning of signing this 

form 

Emergency Repatriation Request for 

Cost Approval and Federal Support 

(Form RR–08) 

The purpose of this form is for states 

to request pre-approval for costs or 

federal support for an emergency 

repatriation. Proposed revisions include 

the following: 

• Changing the title of the form from 

‘State Request for Federal Support’ 

to ‘Emergency Repatriation Request 

for Cost Approval and Federal 

Support’ 

• Adding separate sections for 

description and justification of cost 

pre-approvals and federal support 

requests 

• Modifying section on Federal 

official’s determination of state’s 

request 

Respondents: States, territories, local 

social service providers, administrative 

staff, repatriates, and authorized 

representatives of repatriates. 

ANNUAL BURDEN ESTIMATES

Instrument Total number 

of respondents 

Annual number 

of responses 

per respondent 

Average 

burden hours 

per response 

Annual burden 

hours 

Emergency Repatriation Eligibility Application .............................................. 1,000 1 .5 500 

Emergency Repatriation Reimbursement Request ....................................... 10 1 .3 3 

Loan Waiver and Deferral Application ........................................................... 100 1 .5 50 

Routine Repatriation Reimbursement Request ............................................. 25 10 .3 75 

Repatriation Repayment and Privacy Agreement ......................................... 800 1 .17 136 

Refusal of Temporary Assistance .................................................................. 300 1 .05 15 

Temporary Assistance and Extension Request ............................................ 25 1 .3 8 

Emergency Repatriation Request for Cost Approval and Federal Support .. 5 10 .3 15 

Estimated Total Annual Burden 

Hours: 802. 

Comments: The Department 

specifically requests comments on (a) 

whether the proposed collection of 

information is necessary for the proper 

performance of the functions of the 

agency, including whether the 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices 6571 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) the quality, utility, 

and clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Consideration will be given 

to comments and suggestions submitted 

within 60 days of this publication. 

Authority: 42 U.S.C. 1313, 24 U.S.C. 

321–329. 

Mary B. Jones, 

ACF/OPRE Certifying Officer. 

[FR Doc. 2022–02374 Filed 2–3–22; 8:45 am] 

BILLING CODE 4184–PL–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2022–N–0082] 

Vaccines and Related Biological 

Products Advisory Committee; Notice 

of Meeting; Establishment of a Public 

Docket; Request for Comments 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; establishment of a 

public docket; request for comments. 

SUMMARY: The Food and Drug 

Administration (FDA) announces a 

forthcoming public advisory committee 

meeting of the Vaccines and Related 

Biological Products Advisory 

Committee (VRBPAC). The general 

function of the committee is to provide 

advice and recommendations to FDA on 

regulatory issues. The meeting will be 

open to the public. FDA is establishing 

a docket for public comment on this 

document. 

DATES: The meeting will be held on 

February 15, 2022, from 8:30 a.m. to 5 

p.m. Eastern Time. 

ADDRESSES: Please note that due to the 

impact of this COVID–19 pandemic, all 

meeting participants will be joining this 

advisory committee meeting via an 

online teleconferencing platform. The 

online web conference meeting will be 

available at the following link on the 

day of the meeting: https://youtu.be/ 

nGRNfZ8ZHN8. 

FDA is establishing a docket for 

public comment on this meeting. The 

docket number is FDA–2022–N–0082. 

The docket will close on February 14, 

2022. Submit either electronic or 

written comments on this public 

meeting by February 14, 2022. Please 

note that late, untimely filed comments 

will not be considered. The https://

www.regulations.gov electronic filing 

system will accept comments until 

11:59 p.m. Eastern Time at the end of 

February 14, 2022. Comments received 

by mail/hand delivery/courier (for 

written/paper submissions) will be 

considered timely if they are received 

on or before that date. 

Comments received on or before 

February 10, 2022, will be provided to 

the committee. Comments received after 

February 10, 2022, and by February 14, 

2022, will be taken into consideration 

by FDA. In the event that the meeting 

is cancelled, FDA will continue to 

evaluate any relevant applications or 

information, and consider any 

comments submitted to the docket, as 

appropriate. 

You may submit comments as 

follows: 

Electronic Submissions 

Submit electronic comments in the 

following way: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

Comments submitted electronically, 

including attachments, to https://

www.regulations.gov will be posted to 

the docket unchanged. Because your 

comment will be made public, you are 

solely responsible for ensuring that your 

comment does not include any 

confidential information that you or a 

third party may not wish to be posted, 

such as medical information, your or 

anyone else’s Social Security number, or 

confidential business information, such 

as a manufacturing process. Please note 

that if you include your name, contact 

information, or other information that 

identifies you in the body of your 

comments, that information will be 

posted on https://www.regulations.gov. 

• If you want to submit a comment 

with confidential information that you 

do not wish to be made available to the 

public, submit the comment as a 

written/paper submission and in the 

manner detailed (see ‘‘Written/Paper 

Submissions’’ and ‘‘Instructions’’). 

Written/Paper Submissions 

Submit written/paper submissions as 

follows: 

• Mail/Hand Delivery/Courier (for 

written/paper submissions): Dockets 

Management Staff (HFA–305), Food and 

Drug Administration, 5630 Fishers 

Lane, Rm. 1061, Rockville, MD 20852. 

• For written/paper comments 

submitted to the Dockets Management 

Staff, FDA will post your comment, as 

well as any attachments, except for 

information submitted, marked and 

identified, as confidential, if submitted 

as detailed in ‘‘Instructions.’’ 

Instructions: All submissions received 

must include the Docket No. FDA– 

2022–N–0082 for ‘‘Vaccines and Related 

Biological Products Advisory 

Committee; Notice of Meeting; 

Establishment of a Public Docket; 

Request for Comments.’’ Received 

comments, those filed in a timely 

manner (see ADDRESSES), will be placed 

in the docket and, except for those 

submitted as ‘‘Confidential 

Submissions,’’ publicly viewable at 

https://www.regulations.gov or at the 

Dockets Management Staff between 9 

a.m. and 4 p.m., Eastern Time, Monday 

through Friday, 240–402–7500. 

• Confidential Submissions—To 

submit a comment with confidential 

information that you do not wish to be 

made publicly available, submit your 

comments only as a written/paper 

submission. You should submit two 

copies total. One copy will include the 

information you claim to be confidential 

with a heading or cover note that states 

‘‘THIS DOCUMENT CONTAINS 

CONFIDENTIAL INFORMATION.’’ FDA 

will review this copy, including the 

claimed confidential information, in its 

consideration of comments. The second 

copy, which will have the claimed 

confidential information redacted/ 

blacked out, will be available for public 

viewing and posted on https://

www.regulations.gov. Submit both 

copies to the Dockets Management Staff. 

If you do not wish your name and 

contact information be made publicly 

available, you can provide this 

information on the cover sheet and not 

in the body of your comments and you 

must identify the information as 

‘‘confidential.’’ Any information marked 

as ‘‘confidential’’ will not be disclosed 

except in accordance with 21 CFR 10.20 

and other applicable disclosure law. For 

more information about FDA’s posting 

of comments to public dockets, see 80 

FR 56469, September 18, 2015, or access 

the information at: https://

www.govinfo.gov/content/pkg/FR-2015- 

09-18/pdf/2015-23389.pdf. 

Docket: For access to the docket to 

read background documents or the 

electronic and written/paper comments 

received, go to https://

www.regulations.gov and insert the 

docket number, found in brackets in the 

heading of this document, into the 

‘‘Search’’ box and follow the prompts 

and/or go to the Dockets Management 

Staff, 5630 Fishers Lane, Rm. 1061, 

Rockville, MD 20852, 240–402–7500. 

FOR FURTHER INFORMATION CONTACT: 

Prabhakara Atreya or Christina Vert, 

Center for Biologics Evaluation and 


lotter on DSK11XQN23PROD with NOTICES1